New benchmark exposes persistent weaknesses in AI molecular design tools
A new benchmark called MolGenBench evaluated 17 generative models for structure-based drug design and found persistent weaknesses in producing reliable ...
Tag: AI drug discovery
AI-Designed Pan-TEAD Inhibitor ISM6331 to Show First Human Data at ESMO 2026
Insilico Medicine will present the first clinical data for its AI-designed pan-TEAD inhibitor ISM6331 in a Rapid Oral session at ...
AI Uncovers Bufalin as Estrogen Receptor Degrader
In a groundbreaking convergence of artificial intelligence and molecular pharmacology, researchers have unveiled Bufalin as a novel molecular glue degrader ...
KAIST Develops AI Technology to Automatically Design Optimal Drug Candidates Targeting Cancer Mutations
In a groundbreaking advancement poised to revolutionize pharmaceutical development, researchers at the Korea Advanced Institute of Science and Technology (KAIST) ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!